Computer-aided polyp detection multicenter international randomized controlled study with a focus on community clinics: Gastroenterology Artificial INtelligence system for detecting colorectal polyps - 16/07/26
, R. Scooter Plowman, MD, MBA, MHSA 2, 3, Lindsey Surace, MD 4, 5, Emmanuel Gorospe, MD, MPH 6, 7, Jesse Lachter, MD 8, Dana Ben-Ami Shor, MD 9, Keith Friedenberg, MD, MBA 10, David A. Leiman, MD, MSHP 11, Simon Schlachter, PhD 3, Anil Patwardhan, PhD 3, Roman Goldenberg, PhD 3, Ehud Rivlin, PhD 3, Leera Choi, BA 3, Nayantara Coelho-Prabhu, MD 1, Tonya Kaltenbach, MD 12, Michael Wallace, MD, MPH 13Abstract |
Background and Aims |
Computer-aided polyp detection (CADe) systems can enhance polyp detection, although their performance has largely been evaluated at academic rather than community practices. This randomized controlled trial evaluated the impact of the DEtection of Elusive Polyps-2 (DEEP 2 ) CADe system on colonoscopy quality metrics.
Methods |
Participants undergoing routine colonoscopies were randomized to a control arm, standard-of-care high-definition white-light endoscopy (HD-WLE), or an intervention arm, HD-WLE with real-time DEEP 2 system assistance. Coprimary end points: adenomas per colonoscopy (APC; superiority evaluation at a 0.025 level of significance), and percent positive agreement (PPA, defined [per regulatory request] as the proportion of histologically confirmed clinically significant excised lesions relative to total lesions; noninferiority evaluation with a lower 95% CI threshold of −10%). Secondary end points included adenoma detection rate (ADR), polyp detection rate, polyps per colonoscopy, false positive rate, and false alarm rate.
Results |
This study enrolled 1407 participants, most in community clinics ( n = 1208, 85.9%). Use of the DEEP 2 system resulted in significantly higher APC (0.74 vs 0.60; difference, 0.14; P = .0002). The PPA difference was −0.06 (95% CI, −0.15 to 0.03; P = .09). There was a numerical, but not statistically significant, ADR improvement (42.9% vs 38.9%; P = .031). A post hoc analysis revealed significant benefit in APC and ADR with the DEEP 2 system only within community clinics.
Conclusions |
These results support the incorporation of CADe devices into colonoscopy practice for improving efficacy and quality over standard-of-care, particularly in community practices.
Le texte complet de cet article est disponible en PDF.Abbreviations : ADR, AI, APC, CADe, DEEP 2 , FAR, FPR, GAIN, HD-WLE, ITT, LS, mITT, MWT, PDR, PPA, PPC
Plan
| Clinicaltrials.gov identifier: NCT05275556. Study registered: February 25, 2022; study started: March 1, 2022; enrolment: March 1, 2022 to October 26, 2023. |
Vol 104 - N° 2
P. 277 - août 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
